Where is Ascletis headquartered?

Ascletis is located in Hangzhou, zhejiang province.

Who invested in Ascletis?

Ascletis has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Ascletis?

Ascletis closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

ascletis.com

Ascletis

Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases.

Business Model:

Revenue: $0

Employees: 201-500

Geographic Data

Address: 1785 Jianghai Road,building No.1,

City: Hangzhou

State: zhejiang province

Zip: 311100

Country: CN

Financial Info

Stage:

series b

Raised Last:

$100M

Raised Total:

$255M

Social

Crunchbase

Metrics

9,948,580Website Global Rank

76Website Monthly Traffic

Twitter Followers

Description

Ascletis is engaged in discovering and developing specialty therapeutics for the treatment of cancer and infectious diseases.

Contact Phone:

Contact Email:

IPO Details

Ascletis went public on 11/19/2019 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
11/19/2019

Ticker Symbol:
01672

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction
2/2021	Sagimet Biosciences	Venture Round
8/2019	Sagimet Biosciences	Series E
2/2019	Sagimet Biosciences	Series E
2/2021	Sagimet Biosciences	Venture Round
8/2019	Sagimet Biosciences	Series E
2/2019	Sagimet Biosciences	Series E

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
9/2015	Series B		$0	C-Bridge Capital Tasly Pharmaceutical Pavillion Capital C-Bridge Capital C-Bridge Capital Tasly Pharmaceutical Pavillion Capital C-Bridge Capital
12/2015	Venture Round	1	$20M	Goldman Sachs Goldman Sachs Goldman Sachs Goldman Sachs
8/2018	IPO		-
1/2017	Series B		$0	Focus Media Tasly Pharmaceutical QianHai Equity Investment WTT Investment Goldman Sachs C-Bridge Capital C-Bridge Capital Focus Media Tasly Pharmaceutical QianHai Equity Investment WTT Investment Goldman Sachs C-Bridge Capital C-Bridge Capital
4/2011	Series A	1	$100M	Hangzhou Binjiang Investment Holding Hangzhou Binjiang Investment Holding
8/2018	IPO		-
1/2017	Series B	6	$100M	C-Bridge Capital Goldman Sachs Tasly Pharmaceuticals, Inc Tasly Pharmaceutical Focus Media QianHai Equity Investment WTT Investment Goldman Sachs C-Bridge Capital C-Bridge Capital
9/2015	Equity	3	$35M	C-Bridge Capital Tasly Pharmaceuticals, Inc C-Bridge Capital Tasly Pharmaceutical Pavillion Capital C-Bridge Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details